Kura spins diabetes work into a Lilly-backed biotech startup

Kura spins diabetes work into a Lilly-backed biotech startup is a pharma and life sciences industry update from BioPharma Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Gwendolyn Wu · 2026-09-09

Caspian Therapeutics aims to develop menin inhibitors, which have proven effective against leukemia, for diabetes and other cardiometabolic conditions.

Source: BioPharma Dive